What is FlexDex?
FlexDex has developed a proprietary platform designed to enhance surgical performance through advanced minimally invasive instruments. The company's technology aims to provide surgeons with superior control and dexterity during complex procedures, thereby improving patient outcomes. Operating within the competitive medical device market, FlexDex's focus on innovation positions it as a key player in advancing surgical techniques and patient care. The company's commitment to developing high-performance tools for minimally invasive surgery is central to its market strategy.
How much funding has FlexDex raised?
FlexDex has raised a total of $23.8M across 6 funding rounds:
Series A
$825K
Series B
$5M
Debt
$4.3M
Debt
$350K
Debt
$368K
Other Financing Round
$13M
Series A (2014): $825K, investors not publicly disclosed
Series B (2016): $5M, investors not publicly disclosed
Debt (2017): $4.3M, investors not publicly disclosed
Debt (2020): $350K featuring PPP
Debt (2021): $368K backed by PPP
Other Financing Round (2021): $13M with participation from Almeda Ventures and Johnson & Johnson Innovation
Key Investors in FlexDex
Almeda Ventures
Almeda Ventures is an investment firm that likely focuses on supporting innovative companies within the healthcare and technology sectors, given its participation in FlexDex's funding round.
Johnson & Johnson Innovation
Johnson & Johnson Innovation is a pharmaceutical manufacturing company founded in 1973 that focuses on positively impacting human health through innovation. The company partners with entrepreneurs and early-stage businesses to develop healthcare solutions that improve lives globally. Johnson & Johnson Innovation operates through a network of regional innovation centers in Boston, California, London, and Shanghai, designed to access the best science and technology in each region. The company provides resources and collaborative approaches across multiple healthcare sectors including consumer products, medical devices, pharmaceuticals, and global public health. Johnson & Johnson Innovation aims to create a leading global innovation network that generates transformational healthcare solutions through strategic partnerships with both B2B and B2C applications.
PPP
Public-Private Partnership
What's next for FlexDex?
With the recent injection of $13M in strategic capital, FlexDex is poised for accelerated growth and further development of its surgical instrument platform. This major enterprise-level funding is expected to fuel expansion initiatives, potentially including scaling manufacturing operations, enhancing research and development efforts, and broadening market penetration. The company's trajectory suggests a move towards wider adoption of its technology in surgical settings, reinforcing its position as a significant innovator in the medical device industry. Future strategic investments will likely focus on solidifying its market leadership and exploring new applications for its core technology.
See full FlexDex company page
